Inhibitor Therapeutics, Inc. Income Tax Expense
Inhibitor Therapeutics, Inc. (INTI) reported Income Tax Expense of $55.11 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. income tax expense (benefit) for fiscal 2022 was $55.11K.
- Inhibitor Therapeutics, Inc. income tax expense (benefit) for fiscal 2021 was $0.00.
- Inhibitor Therapeutics, Inc. income tax expense (benefit) for fiscal 2020 was $0.00.
- Inhibitor Therapeutics, Inc. income tax expense (benefit) for fiscal 2019 was $0.00.
| Period end | Income Tax Expense (Benefit) 12 month |
|---|---|
| 2022-12-31 | $55.11K 10-K · filed 2024-03-29 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-26 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-07 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-16 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-17 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-01 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-13 |